Lantern Pharma Inc (LTRN) reports increased R&D expenses and net loss, while advancing AI-driven drug trials and maintaining a strong cash position.
Clearside Biomedical Inc (CLSD) reports significant clinical progress and regulatory milestones, while addressing funding needs for future trials.
Discover Sportsman's Warehouse's Q4 2024 earnings insights! Learn about their transformation strategy, growth in core categories, and strategic goals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results